{"id":1,"date":"2024-12-19T10:00:00","date_gmt":"2024-12-19T10:00:00","guid":{"rendered":"https:\/\/cninmed.com\/wordpress\/?p=1"},"modified":"2025-09-01T01:40:33","modified_gmt":"2025-09-01T01:40:33","slug":"hello-world","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2024\/1.html","title":{"rendered":"[China BD deal 2024]Hansoh and MSD enters a 2 billion USD license on GLP-1Ra  HS-10535"},"content":{"rendered":"\n<p>Announced Date: 2024-12-18 (December 18, 2024)<\/p>\n\n\n\n<p>Asset Name: HS-10535<\/p>\n\n\n\n<p>Licensor: Hansoh Pharma&nbsp; (China)<\/p>\n\n\n\n<p>Licensee (Buyer): \u00a0MSD (Merck &amp; Co., Inc. USA)<\/p>\n\n\n\n<p>.<\/p>\n\n\n\n<p>Asset Modality: Small Molecule<\/p>\n\n\n\n<p>Asset Target: Oral GLP-1 receptor agonist (GLR-IRa)<\/p>\n\n\n\n<p>Current Stage: preclinical&nbsp;<\/p>\n\n\n\n<p>Scope of Authority:<\/p>\n\n\n\n<p>Hansoh Pharma has granted MSD an exclusive global license to develop, manufacture and commercialize HS-10535.<\/p>\n\n\n\n<p>.<\/p>\n\n\n\n<p>Deal Detail:<\/p>\n\n\n\n<p>Upfront payment of\u00a0$112 million,<\/p>\n\n\n\n<p>Milestone payments up to \u00a0$1.9 billion,<\/p>\n\n\n\n<p>Total up to $2.02 billion.<\/p>\n\n\n\n<p>.<\/p>\n\n\n\n<p>Link:<\/p>\n\n\n\n<p>MSD Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist<\/p>\n\n\n\n<p><a href=\"https:\/\/www.msd.com\/news\/msd-enters-into-exclusive-global-license-agreement-with-hansoh-pharma-for-investigational-oral-glp-1-receptor-agonist\/\">https:\/\/www.msd.com\/news\/msd-enters-into-exclusive-global-license-agreement-with-hansoh-pharma-for-investigational-oral-glp-1-receptor-agonist\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announced Date: 2024-12-18 (December 18, 2024) Asset Name: HS-10535 Licensor: Hansoh Pharma&nbsp; (China) Licensee (Buyer): \u00a0MSD &hellip; <a title=\"[China BD deal 2024]Hansoh and MSD enters a 2 billion USD license on GLP-1Ra  HS-10535\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2024\/1.html\"><span class=\"screen-reader-text\">[China BD deal 2024]Hansoh and MSD enters a 2 billion USD license on GLP-1Ra  HS-10535<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1","post","type-post","status-publish","format-standard","hentry","category-china-license-out"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/1","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=1"}],"version-history":[{"count":3,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/1\/revisions"}],"predecessor-version":[{"id":103,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/1\/revisions\/103"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=1"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=1"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=1"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}